Maryam Shabani

Maryam Shabani

Auto-generated profile, based on publicly available information

Maryam Shabani

Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
REReyhane Ebrahimi
Reyhane Ebrahimi
PPParvin Pasalar
Parvin Pasalar
HSHajar Shokri
Hajar Shokri
MSMaryam Shabani
Maryam Shabani
SESolaleh Emamgholipour
Solaleh Emamgholipour

1 January 2012 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
SBSeyed Morteza Bagheri
Seyed Morteza Bagheri
MSMorteza Saneitaheri
Morteza Saneitaheri
RPRamin Pourghorban
Ramin Pourghorban
MSMaryam Shabani
Maryam Shabani
We intend to describe the imaging findings of sudden cardiac arrest occurring during computed tomographic (CT) examination and also of impending cardiogenic shock in 4 patients. Despite rare reports of acute cardiac arrest occurring during or shortly after CT scan, CT features are quite characteristic. Familiarity with CT findings of these patients is essential for accurate interpretation of images, immediate initiation of resuscitation, as well as informing clinical physician in these conditions.

1 July 2013 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
EAElaheh Anvar
Elaheh Anvar
SHSeyed Masoud Hosseini
Seyed Masoud Hosseini
MKMasoumeh Tavasoti Kheiri
Masoumeh Tavasoti Kheiri
VMVahideh Mazaheri
Vahideh Mazaheri
KFKurosh Fazaei
Kurosh Fazaei
ATAli Torabi
Ali Torabi
Serological Survey of Avian Influenza (H9N2) Among Different Occupational Groups in Tehran and Qazvin Provinces in IR Iran - Jundishapur Journal of Microbiology - - Kowsar

28 December 2023 in Acta Biochimica Iranica
Verified
Journal Article
Open access
HHHossein Hosseini
Hossein Hosseini
MRMarzieh Rohani-Rasaf
Marzieh Rohani-Rasaf
AVAkram Vatannejad
Akram Vatannejad
AKAsma Kheirollahi
Asma Kheirollahi
MSMaryam Shabani
Maryam Shabani
MTMaryam Teimouri
Maryam Teimouri
Objectives: Recently, the counts of leukocyte subtypes to HDL-C concentration ratios, including monocyte to HDL-C ratio (MHR), neutrophil to HDL-C ratio (NHR), lymphocyte to HDL-C (LHR) have been proposed as potential new indices of inflammation. This study aims to investigate the correlation between these indices with the severity and mortality of COVID-19. Methods: This study is performed on 1224 non-vaccinated and hospitalized COVID-19 patients. The association between blood parameters and indices on admission with severity and mortality are analyzed using multivariate regression models. Receiver operating characteristic curves are used to compare the utility of different blood parameters. Results: The severe patients and deceased groups show low level of HDL-C, high values of WBC, neutrophil, monocyte, eosinophil, WBC/HDL-C, NHR, MHR, LHR, and EHR compared with the mild and survivor groups, respectively (P < 0.05). Multivariate regression analysis reveals that high levels of WBC, neutrophil, WBC/HDL-C, NHR, MHR, EHR, and low levels of HDL-C are still independently associated with severity and mortality after adjusting for age, gender, and comorbidities. The correlation of LHR with severity and mortality is attenuated to insignificance. Also, patients with high eosinophil and monocyte levels have a higher risk of severe disease. According to the AUC values, the best predictors for severity are the level of WBC, neutrophil, and NHR (AUC: 0.724, 0.725, 0.724 respectively), and the best predictors for mortality are WBC/HDL-C and NHR (AUC: 0.788, 0.790 respectively). Conclusion: In summary, low level of HDL-C and high level of WBC, neutrophil, WBC/ HDL-C, NHR, MHR, and EHR which can be easily calculated from the CBC and HDL-C concentrations, may provide valuable and readily available prognostic information for severity and mortality of COVID-19.